Skip to main content
OpenTrials

Clinical trial condition

Biliary Tract Neoplasms

Explore clinical trials studying Biliary Tract Neoplasms. Study availability and eligibility vary by location and protocol.

327 public trials 104 recruiting studies
Refine in advanced search Browse all conditions

Biliary Tract Neoplasms trial results

Recruiting

A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer

NCT07265674

Conditions
Adenocarcinoma, Advanced Biliary Tract Cancer, Biliary Tract Cancer (BTC), +12 more
Locations
  • City of Hope (Site 107) Duarte, California, United States
  • University of California at Irvine (Site 101) Orange, California, United States
  • UCLA Medical Center (Site 117) Santa Monica, California, United States
  • Moffitt Cancer Center Magnolia Campus (Site 123) Tampa, Florida, United States
View all 18 locations
View Trial Details
Recruiting

A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation

NCT07458347

Conditions
Adenocarcinoma, Biliary Tract Diseases, Biliary Tract Neoplasms, +44 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Mass General Brigham Cancer Institute at Massachusetts General Hospital Boston, Massachusetts, United States
View Trial Details
Recruiting

A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies

NCT07197554

Conditions
Adenocarcinoma, Advanced Solid Tumors, Biliary Tract Cancer (BTC), +30 more
Locations
  • The City of Hope National Medical Center Duarte, California, United States
  • Hoag Memorial Hospital Newport Beach, California, United States
  • Mass General Brigham Cancer Institute Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details

Related conditions